摘要
目的探讨布地奈德混悬剂雾化吸入治疗小儿支原体肺炎的临床疗效。方法选取2015年1月-2016年12月在新疆维吾尔自治区第二济困医院儿科病区住院的符合支原体肺炎诊断100例,按照入院单双日,随机分成两组,在常规给予静脉红霉素抗感染基础上,配合布地奈德雾化吸入治疗的,对两组患儿治疗后3~7 d,对咳嗽、喘息缓解的程度、肺部体征及住院天数进行观察。结果治疗组在改善症状方面疗效显著。结论小儿支原体肺炎在常规性治疗的基础上配合布地奈德混悬剂雾化吸入,可以缩短病程,提高小儿的生活质量,值得临床推广。
Objective To investigate the clinical efficacy of budesonide suspension through aerosol inhalation in the treatment of children mycoplasma pneumonia. Methods 100 cases being diagnosed with mycoplasma pneumonia and hospitalized at pediatric department of the second aid hospital from January 2015 to December 2016 were chosen. According to admission days, all cases were randomly divided into two groups. One group was given budesonide inhalation therapy after intravenous erythromycin was given. And the other group was only given intravenous erythromycin. After 3 to 7 days treatment, some symptoms such as cough, wheezing, pulmonary signs and mean hospitalization days were observed. Results Budesonide inhalation therapy has significant curative effect on improving symptoms. Conclusion Budesonide suspension inhalation can be used to treat with children mycoplasma pneumonia on the basis of routine treatment, and it can shorten the course of disease and improve the quality of life of children, so it is worthy of clinical promotion.
出处
《新疆医学》
2017年第11期1311-1312,共2页
Xinjiang Medical Journal
关键词
布地奈德混悬剂
雾化吸入
支原体肺炎
Budesonide suspension
Aerosol inhalation
Myeoplasma pneumonia
